Raman on the Brain
An enhanced spectroscopic approach could be the answer to Alzheimer’s biomarker detection
Lauren Robertson |
Despite a large research effort in recent decades, early diagnosis of Alzheimer’s disease (AD) remains challenging. AD biomarkers have proven invaluable, but we still need a sensitive and cost-effective method to detect them. Now, researchers have shown that fiber-enhanced Raman spectroscopy (FERS) could help overcome the limitations of traditional spectroscopic methods and enable reliable detection of amyloid β-peptide – a major AD biomarker (1).
The approach involves integrating a hollow-core photonic crystal fiber with conventional Raman spectroscopy and coupling this to surface-enhanced Raman spectroscopy. This enabled the researchers to amplify the weak biomarker Raman signal more than 200-fold. Further research is planned, but the approach takes us one step closer to early AD diagnosis.
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Analytical Scientist site. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Analytical Scientist magazine
- PJ Eravuchira et al., J Biomed Optics, 25, 077001 (2020). DOI: 10.1117/1.JBO.25.7.077001